SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 580 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,875,306 | +512.1% | 55,976 | +190.3% | 0.09% | +475.0% |
Q2 2023 | $1,940,221 | -49.4% | 19,281 | -72.0% | 0.02% | -56.8% |
Q1 2023 | $3,833,658 | -66.3% | 68,890 | -22.1% | 0.04% | -61.1% |
Q4 2022 | $11,360,284 | +49.3% | 88,400 | +25.6% | 0.10% | +50.8% |
Q3 2022 | $7,607,000 | +30.6% | 70,360 | +113.8% | 0.06% | +10.5% |
Q2 2022 | $5,823,000 | +6.1% | 32,912 | -13.6% | 0.06% | +16.3% |
Q1 2022 | $5,489,000 | -16.6% | 38,108 | -10.4% | 0.05% | -18.3% |
Q4 2021 | $6,579,000 | +325.5% | 42,551 | +367.6% | 0.06% | +275.0% |
Q3 2021 | $1,546,000 | -77.5% | 9,100 | -79.1% | 0.02% | -78.1% |
Q2 2021 | $6,885,000 | +275.6% | 43,604 | +230.3% | 0.07% | +231.8% |
Q1 2021 | $1,833,000 | – | 13,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |